BRCA2 and metastatic neoplasm: Intriguingly, while the primary tumors from this patient did not undergo LOH (Table 1; Fig. 3B–D), the metastatic tumors lose the BRCA2 truncating variant, retaining the missense mutated allele (Table 1; Fig. 3E–F and Figure S1B–E).